Acquisition / mergerNotableFiled on BSE ·

Bliss GVS Pharma Ltd announces change in control and board appointments on Sept 28, 2026

Bliss GVS Pharma · Pharmaceuticals & Biotechnology

What the filing says

  • Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited together hold 5,09,86,264 equity shares, 47.95%, and became promoters.
  • Managing Director Narsimha Shibroor Kamath resigned with effect from September 28, 2026, pursuant to completion of the SPA transactions.
  • Hetul Krishnakant Mehta, Amar Dilip Shah and Pramod Badrinarayan Kasat were appointed as Additional Non-Executive Non-Independent Directors, subject to member approval by postal ballot.

Why it's rated notable: no figure in the filing to size it as major

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Meeting Updates

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies Ltd

Electrical Equipment

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Bliss GVS Pharma

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.